Do you want to read an article? Please log in or register.
Direct-Acting Oral Anticoagulants Versus Warfarin in Medicare Patients With Chronic Kidney Disease and Atrial Fibrillation
Stroke
Related content
RECOMMENDED
Stroke
Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation
Lancet Neurol.
Seiffge DJ, Werring DJ, Paciaroni M, Dawson J, Warach S, Milling TJ, Engelter ST, Fischer U, Norrving B
doi: 10.1016/S1474-
RECOMMENDED
Stroke
Ischemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation
★ 1
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Ann Neurol.
Seiffge D, De Marchis GM, Koga M, Paciaroni M, Wilson D, Cappellari M, Macha K, Tsivgoulis G, Ambler G, Arihiro S, Bonati LH, Bonetti B, Kallmünzer B, Muir KW, Bovi P, Gensicke H, Inoue M, Schwab S, Yaghi S, Brown MM, Lyrer P, Takagi M, Acciarrese M, Jager HR, Polymeris AA, Toyoda K, Venti M, Traenka C, Yamagami H, Alberti A, Yoshimura S, Caso V, Engelter ST, Werring DJ, RAF, RAF-DOAC, CROMIS-2, SAMURAI, NOACISP, Erlangen and Verona registry collaborators
doi: 10.1002/ana.25700.
RECOMMENDED
Stroke
Risks of Stroke and Mortality in Atrial Fibrillation Patients Treated With Rivaroxaban and Warfarin
★ 1
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Stroke.
Alberts M, Chen YW, Lin JH, Kogan E, Twyman K, Milentijevic D
doi: 10.1161/STROKEAHA.119.025554.
Stroke
Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Prior Gastrointestinal Bleeding
Stroke
Kwon S, Lee SR, Choi EK, Lee E, Jung JH, Han KD, Cha MJ, Oh S, Lip GYH
doi: 10.1161/STROKEAHA.120.030761
Stroke
Safety of Anticoagulation in Patients Treated With Urgent Reperfusion for Ischemic Stroke Related to Atrial Fibrillation
Stroke.
Giustozzi M, Acciarresi M, Agnelli G, Caso V, Bandini F, Tsivgoulis G, Yaghi S, Furie KL, Tadi P, Becattini C, Zedde M, Abdul-Rahim AH, Lees KR, Alberti A, Venti M, D'Amore C, Giulia Mosconi M, Anna Cimini L, Bovi P, Carletti M, Rigatelli A, Cappellari M, Putaala J, Tomppo L, Tatlisumak T, Marcheselli S, Pezzini A, Poli L, Padovani A, Vannucchi V, Sohn SI, Lorenzini G, Tassi R, Guideri F, Acampa M, Martini G, Ntaios G, Athanasakis G, Makaritsis K, Karagkiozi E, Vadikolias K, Liantinioti C, Theodorou A, Halvatsiotis P, Mumoli N, Galati F, Sacco S, Tiseo C, Corea F, Ageno W, Bellesini M, Silvestrelli G, Ciccone A, Lanari A, Scoditti U, Denti L, Mancuso M, Ferrari E, Ulivi L, Orlandi G, Giannini N, Tassinari T, Luisa De Lodovici M, Rueckert C, Baldi A, Toni D, Letteri F, Giuntini M, Maria Lotti E, Flomin Y, Pieroni A, Kargiotis O, Karapanayiotides T, Monaco S, Maimone Baronello M, Csiba L, Szabó L, Chiti A, Giorli E, Del Sette M, Imberti D, Zabzuni D, Doronin B, Volodina V, Michel P, Vanacker P, Barlinn K, Barlinn J, Deleu D, Gourbali V, Paciaroni M, Masotti L
doi: 10.1161/STROKEAHA.
Stroke
Risk Factors for Intracerebral Hemorrhage in Patients With Atrial Fibrillation on Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention
Stroke
Paciaroni M, Agnelli G, Giustozzi M, Caso V, Toso E, Angelini F, Canavero I, Micieli G, Antonenko K, Rocco A, Diomedi M, Katsanos AH, Shoamanesh A, Giannopoulos S, Ageno W, Pegoraro S, Putaala J, Strbian D, Sallinen H, Mac Grory BC, Furie KL, Stretz C, Reznik ME, Alberti A, Venti M, Mosconi MG, Vedovati MC, Franco L, Zepponi G, Romoli M, Zini A, Brancaleoni L, Riva L, Silvestrelli G, Ciccone A, Zedde ML, Giorli E, Kosmidou M, Ntais E, Palaiodimou L, Halvatsiotis P, Tassinari T, Saia V, Ornello R, Sacco S, Bandini F, Mancuso M, Orlandi G, Ferrari E, Pezzini A, Poli L, Cappellari M, Forlivesi S, Rigatelli A, Yaghi S, Scher E, Frontera JA, Masotti L, Grifoni E, Caliandro P, Zauli A, Reale G, Marcheselli S, Gasparro A, Terruso V, Arnao V, Aridon P, Abdul-Rahim AH, Dawson J, Saggese CE, Palmerini F, Doronin B, Volodina V, Toni D, Risitano A, Schirinzi E, Del Sette M, Lochner P, Monaco S, Mannino M, Tassi R, Guideri F, Acampa M, Martini G, Lotti EM, Padroni M, Pantoni L, Rosa S, Bertora P, Ntaios G, Sagris D, Baldi A, D'Amore C, Mumoli N, Porta C, Denti L, Chiti A, Corea F, Acciarresi M, Flomin Y, Popovic N, Tsivgoulis G
doi: 10.1161/STROKEAHA.120.031827
Stroke
Rivaroxaban vs Warfarin Sodium in the Ultra-Early Period After Atrial Fibrillation-Related Mild Ischemic Stroke: A Randomized Clinical Trial
JAMA Neurol.
Hong KS, Kwon SU, Lee SH, Lee JS, Kim YJ, Song TJ, Kim YD, Park MS, Kim EG, Cha JK, Sung SM, Yoon BW, Bang OY, Seo WK, Hwang YH, Ahn SH, Kang DW, Kang HG, Yu KH; Phase 2 Exploratory Clinical Study to Assess the Effects of Xarelto (Rivaroxaban) Versus Warfarin on Ischemia, Bleeding, and Hospital Stay in Acute Cerebral Infarction Patients With Non-valvular Atrial Fibrillation (Triple AXEL) Study Group
doi: 10.1001/
Stroke
Association of Oral Anticoagulation With Stroke in Atrial Fibrillation or Heart Failure: A Comparative Meta-Analysis
Stroke
Reddin C, Judge C, Loughlin E, Murphy R, Costello M, Alvarez A, Ferguson J, Smyth A, Canavan M, O'Donnell MJ
doi: 10.1161/STROKEAHA.120.033910
RECOMMENDED
Stroke
Safety of Intravenous Thrombolysis Among Patients Taking Direct Oral Anticoagulants: A Systematic Review and Meta-Analysis
★ 1
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Stroke.
Shahjouei S, Tsivgoulis G, Goyal N, Sadighi A, Mowla A, Wang M, Seiffge DJ, Zand R
doi: 10.1161/STROKEAHA.119.026426.